- Home
- FTAIM vs OSRHW Comparison
FTAIM vs OSRHW Comparison
Compare FTAIM & OSRHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
FTAIM
FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares
Current Price
Company Overview
Basic Information| Metric | FTAIM | OSRHW |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 580 | 21 |
| Industry | Misc Corporate Leasing Services | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | FTAIM | OSRHW |
|---|---|---|
| Price | $27.37 | $0.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.3K | ★ 27.7K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.60 | $0.03 |
| 52 Week High | $27.49 | $0.08 |
Technical Indicators
Market Signals| Indicator | FTAIM | OSRHW |
|---|---|---|
| Relative Strength Index (RSI) | 59.58 | 51.31 |
| Support Level | $26.39 | $0.04 |
| Resistance Level | $27.49 | $0.07 |
| Average True Range (ATR) | 0.25 | 0.00 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 100.00 | 56.86 |
Price Performance
Historical ComparisonAbout FTAIM FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares
FTAI Aviation Ltd is an aerospace company. It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft, which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.
About OSRHW OSR Holdings Inc. Warrant
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.